Business Context and Reporting Period
Company: Reinsurance Group of America, Incorporated (RGA)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Three months ended March 31, 2026
Business Overview: RGA is a leading global provider of life reinsurance and financial solutions, including traditional reinsurance (life, health, disability) and financial solutions (longevity, asset-intensive products, pension risk transfer). As of March 31, 2026, the Company held $4.3 trillion of life reinsurance in force and total assets of $164.1 billion.
Key Financial Metrics
| Metric | Q1 2026 | Q1 2025 |
|---|---|---|
| Total Revenues | $6,494 million | $5,260 million |
| Net Income | $331 million | $288 million |
| Net Income Available to Shareholders | $330 million | $286 million |
| Diluted Earnings Per Share | $4.98 | $4.27 |
| Net Investment Income | $1,701 million | $1,232 million |
| Investment Related Gains (Losses), Net | $(170) million | $(79) million |
| Operating Cash Flow | $2,873 million | $1,429 million |
| Total Assets | $164,064 million | $156,590 million (Dec 31, 2025) |
| Long-Term Debt | $6,105 million | $5,710 million (Dec 31, 2025) |
| Cash and Cash Equivalents | $4,993 million | $4,168 million (Dec 31, 2025) |
Material Changes vs. Prior Period
- Revenue Growth: Total revenues increased by $1,234 million (23.5%) year-over-year, driven by a $576 million increase in net premiums and a $469 million increase in net investment income.
- Profitability: Net income increased by $43 million (15%). Income before taxes rose to $441 million from $369 million.
- Investment Performance: Net investment income grew significantly due to a larger invested asset base and higher variable investment income. However, investment-related losses widened to $(170) million from $(79) million, primarily due to portfolio repositioning losses and fair value changes in derivatives.
- Claims Experience: Claims and other policy benefits increased by $799 million to $4,621 million, reflecting higher volumes and the impact of new business.
- Foreign Currency: Strengthening of the British pound, Canadian dollar, and Euro contributed a $20 million increase to income before taxes.
Guidance, Outlook, and Management Commentary
- Strategic Transactions: A significant driver of Q1 2026 results was the July 31, 2025 transaction with Equitable Holdings, where RGA assumed a 75% quota share of individual life insurance liabilities (approx. $12 billion). This transaction increased income before taxes by $39 million in the quarter.
- Capital Deployment: On January 29, 2026, the Board authorized a $500 million share repurchase program. During Q1 2026, the Company repurchased 225,638 shares for approximately $50 million, leaving $450 million remaining. A quarterly dividend of $0.93 per share was declared in April 2026.
- Debt Activity: On March 3, 2026, RGA issued $400 million of 6.375% subordinated debentures due 2056. The Company also announced the redemption of $400 million of 5.75% subordinated debentures due 2056, scheduled for June 15, 2026.
- Liquidity: Management believes liquidity sources are sufficient to cover claims and obligations. The Company maintains an $850 million revolving credit facility (undrawn) and $302 million in available FHLB borrowings.
- Risks: Key risks include mortality/morbidity fluctuations, investment credit quality, interest rate volatility, and foreign currency exchange rates. The Company noted no material changes to risk factors from the 2025 Annual Report.
Investor Verification Checklist
- Equitable Holdings Transaction Impact: Verify the ongoing contribution of the $12 billion liability assumption to future quarters and its effect on capital requirements.
- Investment Portfolio Quality: Review the increase in gross unrealized losses on fixed maturity securities (from $7.0 billion to $8.5 billion) and the $43 million in credit loss allowances/impairments.
- Derivative Exposure: Assess the impact of the $57 million increase in fair value losses on freestanding derivatives on future earnings volatility.
- Debt Refinancing: Confirm the execution of the June 2026 redemption of the 5.75% debentures and the cost of capital implications of the new 6.375% issuance.
- Share Repurchase Execution: Monitor the pace of the remaining $450 million share repurchase authorization relative to share price.